Dellora Investments

Overview

Dellora Investments is a private investment firm specializing in the healthcare and biotechnology sectors. The firm employs a concentrated, long-short equity investing strategy, targeting publicly traded small and mid-cap biotechnology, pharmaceuticals, and medical technology companies. Dellora seeks investment opportunities that produce uncorrelated returns based on intrinsic value-based fundamental analyses. The firm is based in Greenwich, Connecticut. The team at Dellora Investments is led by Chief Investment Officer and Managing Partner Kevin Pyun, who has over a decade of experience in healthcare-focused investment management. Other key team members include Senior Investment Analysts Jennifer Teubl, PhD, and Neil Puri, MD, both bringing extensive backgrounds in healthcare investment research. The firm's Chief Financial Officer and Chief Operating Officer is Jae Park, who has a strong background in financial operations within the investment sector. Dellora Investments has demonstrated a commitment to its investment philosophy by raising $400,000 in a seed funding round for its Dellora Long Only Master Fund in March 2025. This initiative reflects the firm's dedication to identifying innovation, impact, and dislocations in the life sciences space, aiming to generate uncorrelated returns through fundamental analysis of healthcare and biotechnology companies.

Investment Focus

• Focus on healthcare and biotechnology sectors
• Targeting small and mid-cap companies
• Preference for uncorrelated returns based on intrinsic value analysis